Integrative Analysis of MicroRNA-Mediated Gene Signatures and Pathways Modulating White Blood Cell Count in Childhood Acute Lymphoblastic Leukemia
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by SAGE Publications in Biomarker Insights
- Vol. 12
Abstract
MicroRNAs (miRNAs) regulate the expression of protein-coding genes and represent potential biomarkers for childhood acute lymphoblastic leukemia (ALL). However, information linking miRNAs with their messenger RNA (mRNA) target genes modulating white blood cell (WBC) count is lacking. Here, we analyzed miRNAs and gene expression data from pediatric patients with ALL to identify a signature of miRNAs involved in ALL and their mRNA target genes, molecular networks, and biological pathways modulating WBC. We discovered a signature of miRNAs differentially expressed in ALL and a signature of mRNA target genes distinguishing patients with high WBC from patients with low WBC. In addition, we identified molecular networks and biological pathways, among them PI3/AKT, JAK/STAT, IL-17, TGF-β, apoptosis, IL-15, STAT3, IGF-1, FGF, mTOR, VEGF, NF-kB, and P53 signaling pathways, enriched for or targeted by miRNAs. The discovered miRNAs and their target genes and pathways represent potential clinically actionable biomarkers and therapeutic targets.Keywords
This publication has 36 references indexed in Scilit:
- A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALLHuman Molecular Genetics, 2011
- MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemiaHaematologica, 2011
- Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeBlood, 2010
- High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studiesEuropean Journal of Haematology, 2010
- Reprogramming of miRNA networks in cancer and leukemiaGenome Research, 2010
- Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaBlood, 2010
- Pomelo II: finding differentially expressed genesNucleic Acids Research, 2009
- GenePattern 2.0Nature Genetics, 2006
- Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemiaBlood, 2005
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002